Leading sponsors are rethinking how technology can transform site performance, data quality, and monitoring efficiency.
In this new case study, discover how a Top 5 pharmaceutical company used CRIO’s Central eSource platform to modernize its global Alzheimer’s disease trial — achieving measurable gains in efficiency, consistency, and cost savings.
Key Results
- 70% site adoption rate through a voluntary, collaborative rollout model
- 59% fewer on-site CRA visits enabled by remote data review
- 30-day faster start-up with standardized protocol-driven source templates
- 24% improvement in monitoring efficiency, reducing downstream cleanup and SDV needs
Inside the Case Study
This real-world example reveals how Central eSource technology:
- Improves data consistency across global research sites
- Reduces manual processes and administrative burden
- Enables remote monitoring and faster decision-making
- Enhances collaboration between sponsors and sites without disrupting site workflows
You’ll also see how the sponsor plans to expand eSource adoption across seven new studies and fully integrate CRIO with their EDC system to eliminate source data verification and boost data accuracy.
Why Read This Case Study
This is more than a technology story, it’s proof that a thoughtful, site-first approach can accelerate study timelines and strengthen sponsor-site relationships.